Table of Contents

December 2005, Volume 12, Number 4

Reviews

    • G A Kaltsas,
    • D Papadogias,
    • P Makras,
    • and A B Grossman

    Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues

    Endocr Relat Cancer 12 (4) 683-699, doi:10.1677/erc.1.01116
    • Takashi Suzuki,
    • Yasuhiro Miki,
    • Yasuhiro Nakamura,
    • Takuya Moriya,
    • Kiyoshi Ito,
    • Noriaki Ohuchi,
    • and Hironobu Sasano

    Sex steroid-producing enzymes in human breast cancer

    Endocr Relat Cancer 12 (4) 701-720, doi:10.1677/erc.1.00834
    • Nicola Normanno,
    • Massimo Di Maio,
    • Ermelinda De Maio,
    • Antonella De Luca,
    • Andrea de Matteis,
    • Antonio Giordano,
    • Francesco Perrone,
    • and on behalf of the NCI-Naples Breast Cancer Group
    • , on behalf of the NCI-Naples Breast Cancer Group

    Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

    Endocr Relat Cancer 12 (4) 721-747, doi:10.1677/erc.1.00857
    • R Serra and
    • M R Crowley

    Mouse models of transforming growth factor β impact in breast development and cancer

    Endocr Relat Cancer 12 (4) 749-760, doi:10.1677/erc.1.00936
    • Anna Bagnato,
    • Francesca Spinella,
    • and Laura Rosanò

    Emerging role of the endothelin axis in ovarian tumor progression

    Endocr Relat Cancer 12 (4) 761-772, doi:10.1677/erc.1.01077
    • B Jarząb,
    • D Handkiewicz-Junak,
    • and J Włoch

    Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

    Endocr Relat Cancer 12 (4) 773-803, doi:10.1677/erc.1.00880
    • Suresh Veeramani,
    • Ta-Chun Yuan,
    • Siu-Ju Chen,
    • Fen-Fen Lin,
    • Juliette E Petersen,
    • Syed Shaheduzzaman,
    • Shiv Srivastava,
    • Richard G MacDonald,
    • and Ming-Fong Lin

    Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer

    Endocr Relat Cancer 12 (4) 805-822, doi:10.1677/erc.1.00950

Original Research

    • B Brandt,
    • D Kemming,
    • J Packeisen,
    • R Simon,
    • M Helms,
    • U Feldmann,
    • A Matuschek,
    • C Kersting,
    • B Hinrichs,
    • J-M Bidart,
    • D Bellet,
    • K Bartkowiak,
    • N Dankbar,
    • T Dittmar,
    • G Sauter,
    • W Boecker,
    • and H Buerger

    Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility

    Endocr Relat Cancer 12 (4) 823-837, doi:10.1677/erc.1.00975
    • P L Jeffery,
    • R E Murray,
    • A H Yeh,
    • J F McNamara,
    • R P Duncan,
    • G D Francis,
    • A C Herington,
    • and L K Chopin

    Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines

    Endocr Relat Cancer 12 (4) 839-850, doi:10.1677/erc.1.00984
    • Amanda J M O’Donnell,
    • Kenneth G Macleod,
    • David J Burns,
    • John F Smyth,
    • and Simon P Langdon

    Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen

    Endocr Relat Cancer 12 (4) 851-866, doi:10.1677/erc.1.01039
    • Giovanna Maria Pierantoni,
    • Palma Finelli,
    • Emanuele Valtorta,
    • Daniela Giardino,
    • Ornella Rodeschini,
    • Francesco Esposito,
    • Marco Losa,
    • Alfredo Fusco,
    • and Lidia Larizza

    High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy

    Endocr Relat Cancer 12 (4) 867-874, doi:10.1677/erc.1.01049
    • Y Dong,
    • L T Bui,
    • D M Odorico,
    • O L Tan,
    • S A Myers,
    • H Samaratunga,
    • R A Gardiner,
    • and J A Clements

    Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms

    Endocr Relat Cancer 12 (4) 875-889, doi:10.1677/erc.1.01062
    • P J Jenkins,
    • S Khalaf,
    • W Ogunkolade,
    • K McCarthy,
    • T David,
    • R E Hands,
    • D Davies,
    • and S A Bustin

    Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis

    Endocr Relat Cancer 12 (4) 891-901, doi:10.1677/erc.1.01080
    • A Rody,
    • U Holtrich,
    • C Solbach,
    • K Kourtis,
    • G von Minckwitz,
    • K Engels,
    • S Kissler,
    • R Gätje,
    • T Karn,
    • and M Kaufmann

    Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions

    Endocr Relat Cancer 12 (4) 903-916, doi:10.1677/erc.1.01088
    • K Wagner,
    • K Hemminki,
    • E Israelsson,
    • E Grzybowska,
    • R Klaes,
    • B Chen,
    • D Butkiewicz,
    • J Pamula,
    • W Pekala,
    • and A Försti

    Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer

    Endocr Relat Cancer 12 (4) 917-928, doi:10.1677/erc.1.01073
    • S Corbetta,
    • L Vicentini,
    • S Ferrero,
    • A Lania,
    • G Mantovani,
    • D Cordella,
    • P Beck-Peccoz,
    • and A Spada

    Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors

    Endocr Relat Cancer 12 (4) 929-937, doi:10.1677/erc.1.00970
    • A Lasco,
    • E Morini,
    • D Maglitto,
    • A Campennì,
    • and S Benvenga

    Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate

    Endocr Relat Cancer 12 (4) 939-944, doi:10.1677/erc.1.01065
    • S E Bojesen,
    • S K Kjær,
    • E V S Høgdall,
    • B L Thomsen,
    • C K Høgdall,
    • J Blaakær,
    • A Tybjærg-Hansen,
    • and B G Nordestgaard

    Increased risk of ovarian cancer in integrin β3 Leu33Pro homozygotes

    Endocr Relat Cancer 12 (4) 945-952, doi:10.1677/erc.1.01083
    • Roberta Malaguarnera,
    • Angelo Mandarino,
    • Emanuela Mazzon,
    • Veronica Vella,
    • Piero Gangemi,
    • Carlo Vancheri,
    • Paolo Vigneri,
    • Alessandra Aloisi,
    • Riccardo Vigneri,
    • and Francesco Frasca

    The p53-homologue p63 may promote thyroid cancer progression

    Endocr Relat Cancer 12 (4) 953-971, doi:10.1677/erc.1.00968
    • J L Reverter,
    • S Holgado,
    • N Alonso,
    • I Salinas,
    • M L Granada,
    • and A Sanmartí

    Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma

    Endocr Relat Cancer 12 (4) 973-981, doi:10.1677/erc.1.01072
    • C Festuccia,
    • P Muzi,
    • D Millimaggi,
    • L Biordi,
    • G L Gravina,
    • S Speca,
    • A Angelucci,
    • V Dolo,
    • C Vicentini,
    • and M Bologna

    Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines

    Endocr Relat Cancer 12 (4) 983-998, doi:10.1677/erc.1.00986
    • Jörg B Engel,
    • Andrew V Schally,
    • Gabor Halmos,
    • Benjamin Baker,
    • Attila Nagy,
    • and Gunhild Keller

    Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins

    Endocr Relat Cancer 12 (4) 999-1009, doi:10.1677/erc.1.01022
    • M Montani,
    • A M Schmitt,
    • S Schmid,
    • T Locher,
    • P Saremaslani,
    • P U Heitz,
    • P Komminoth,
    • and A Perren

    No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma

    Endocr Relat Cancer 12 (4) 1011-1016, doi:10.1677/erc.1.00996
    • L-A Martin,
    • S Pancholi,
    • C M W Chan,
    • I Farmer,
    • C Kimberley,
    • M Dowsett,
    • and S R D Johnston

    The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling

    Endocr Relat Cancer 12 (4) 1017-1036, doi:10.1677/erc.1.00905
    • S C J P Gielen,
    • L C M Kühne,
    • P C Ewing,
    • L J Blok,
    • and C W Burger

    Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study

    Endocr Relat Cancer 12 (4) 1037-1049, doi:10.1677/erc.1.01046
    • Davide Melisi,
    • Rosa Caputo,
    • Vincenzo Damiano,
    • Roberto Bianco,
    • Bianca Maria Veneziani,
    • A Raffaele Bianco,
    • Sabino De Placido,
    • Fortunato Ciardiello,
    • and Giampaolo Tortora

    Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer

    Endocr Relat Cancer 12 (4) 1051-1058, doi:10.1677/erc.1.01061
    • W F Symmans,
    • D J Fiterman,
    • S K Anderson,
    • M Ayers,
    • R Rouzier,
    • V Dunmire,
    • J Stec,
    • V Valero,
    • N Sneige,
    • C Albarracin,
    • Y Wu,
    • J S Ross,
    • P Wagner,
    • R L Theriault,
    • B Arun,
    • H Kuerer,
    • K R Hess,
    • W Zhang,
    • G N Hortobagyi,
    • and L Pusztai

    A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding

    Endocr Relat Cancer 12 (4) 1059-1069, doi:10.1677/erc.1.01051
    • R Kaaks,
    • S Rinaldi,
    • T J Key,
    • F Berrino,
    • P H M Peeters,
    • C Biessy,
    • L Dossus,
    • A Lukanova,
    • S Bingham,
    • K-T Khaw,
    • N E Allen,
    • H B Bueno-de-Mesquita,
    • C H van Gils,
    • D Grobbee,
    • H Boeing,
    • P H Lahmann,
    • G Nagel,
    • J Chang-Claude,
    • F Clavel-Chapelon,
    • A Fournier,
    • A Thiébaut,
    • C A González,
    • J R Quirós,
    • M-J Tormo,
    • E Ardanaz,
    • P Amiano,
    • V Krogh,
    • D Palli,
    • S Panico,
    • R Tumino,
    • P Vineis,
    • A Trichopoulou,
    • V Kalapothaki,
    • D Trichopoulos,
    • P Ferrari,
    • T Norat,
    • R Saracci,
    • and E Riboli

    Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

    Endocr Relat Cancer 12 (4) 1071-1082, doi:10.1677/erc.1.01038
    • Francesco Panzuto,
    • Silvia Nasoni,
    • Massimo Falconi,
    • Vito Domenico Corleto,
    • Gabriele Capurso,
    • Sara Cassetta,
    • Michela Di Fonzo,
    • Valentina Tornatore,
    • Massimo Milione,
    • Stefano Angeletti,
    • Maria Sofia Cattaruzza,
    • Vincenzo Ziparo,
    • Cesare Bordi,
    • Paolo Pederzoli,
    • and Gianfranco Delle Fave

    Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

    Endocr Relat Cancer 12 (4) 1083-1092, doi:10.1677/erc.1.01017
|

This Issue

December 2005; 12 (4)
Cover
  1. Reviews
  2. Original Research

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most